Agomelatine and Vortioxetine both come up in the same conversations; they overlap on Serotonin. Agomelatine: Agomelatine is a first-in-class antidepressant that acts through a mechanism unlike conventional agents, combining agonism at the melatonin MT1 and MT2 receptors with antagonism of the serotonin 5-HT2C receptor. Vortioxetine: Vortioxetine is an antidepressant used to treat major depressive disorder in adults, often described as a serotonin modulator because it combines several actions on the serotonin system.
Agomelatine is a first-in-class antidepressant that acts through a mechanism unlike conventional agents, combining agonism at the melatonin MT1 and MT2 receptors with antagonism of the serotonin 5-HT2C receptor. This dual action resynchronizes disrupted circadian rhythms and increases dopamine and noradrenaline in the frontal cortex, and it is the only marketed antidepressant to work through the melatonergic system rather than monoamine reuptake. Approved in Europe as Valdoxan, it is noted for a relatively favorable tolerability profile, with fewer sexual side effects and less weight gain than SSRIs, though it requires monitoring of liver enzymes because of a risk of hepatotoxicity.
Vortioxetine is an antidepressant used to treat major depressive disorder in adults, often described as a serotonin modulator because it combines several actions on the serotonin system. It both blocks the serotonin transporter, like conventional serotonin reuptake inhibitors, and acts directly on a range of serotonin receptors as an agonist, partial agonist, or antagonist. Approved in the United States and Europe in 2013, it is taken once daily by mouth and has drawn particular interest for possible effects on the cognitive symptoms of depression.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
raises (via 5-HT2C)
antagonist
antagonist
inhibits
agonist
partial agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Agomelatine is currently listed by more trusted vendors (3), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.